LakeShore Biopharma Co., Ltd. financial data

Symbol
LSB, LSBPW on Nasdaq
Location
Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing District, Beijing, China
Fiscal year end
March 31
Latest financial report
20-F - Q1 2025 - Jul 31, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20.8M shares -89.1%
Common Stock, Shares, Outstanding 20.8M shares +9.17%
Common Stock, Value, Issued 3.99K USD +8.32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 53.9M USD
Accounts Receivable, after Allowance for Credit Loss, Current 69.8M USD +11.5%
Inventory, Net 31.7M USD +10.6%
Other Assets, Current 131K USD
Assets, Current 117M USD -7.83%
Deferred Income Tax Assets, Net 3.89M USD +16.9%
Property, Plant and Equipment, Net 57.6M USD -13.7%
Operating Lease, Right-of-Use Asset 118K USD -88.5%
Intangible Assets, Net (Excluding Goodwill) 10.1M USD +1.07%
Other Assets, Noncurrent 1.43M USD -70.4%
Assets 191M USD -10.7%
Accounts Payable, Current 6.9M USD -27.7%
Employee-related Liabilities, Current 7.91M USD -5.36%
Liabilities, Current 115M USD +1.62%
Operating Lease, Liability, Noncurrent 251K USD -72.8%
Liabilities 121M USD -7.54%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.98M USD +2.7%
Retained Earnings (Accumulated Deficit) -335M USD -3.12%
Stockholders' Equity Attributable to Parent 69.6M USD -15.6%
Liabilities and Equity 191M USD -10.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 20.8M shares +9.17%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 15M USD -56.4%
Deferred Tax Assets, Valuation Allowance 14.2M USD +24.4%
Deferred Tax Assets, Gross 3.99M USD +6.02%
Operating Lease, Liability 63.7K USD -93.5%
Lessee, Operating Lease, Liability, to be Paid 65.5K USD -93.5%
Property, Plant and Equipment, Gross 102M USD -8.16%
Operating Lease, Liability, Current 63.7K USD -91.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 256K USD -65.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 65.5K USD -91.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +41.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.85K USD -94.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 222K USD
Deferred Tax Assets, Operating Loss Carryforwards 14.2M USD +24.4%
Additional Paid in Capital 387M USD
Deferred Tax Assets, Net of Valuation Allowance 842K USD